MedTrace Logo

Biomarkers in Samples From Patients With B-Cell Acute Lymphoblastic Leukemia

NCT01505699 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 186

Last updated 2017-05-17

No results posted yet for this study

Summary

RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer.

PURPOSE: This research study is studying biomarkers in samples from patients with acute lymphoblastic leukemia enrolled on ECOG-2993 clinical trial.

Conditions

Interventions

GENETIC

RNA analysis

GENETIC

cytogenetic analysis

GENETIC

microarray analysis

OTHER

laboratory biomarker analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Eastern Cooperative Oncology Group

    lead NETWORK

Principal Investigators

  • Hans-Guido Wendel, MD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
15 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-06
Primary Completion
2012-02-06
Completion
2012-02-06

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01505699 on ClinicalTrials.gov